Clinical experience of the expanded carrier screening for recessive genetic diseases in a large cohort study in Southern central China
Authors:
Open Access
- 25 April 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Abstract
Recessive monogenic disorders represent a significant cause of congenital malformations and disabilities in pediatric populations. The present study aims to provide the first comprehensive assessment of clinical experience with expanded carrier screening (ECS) panels in a large cohort from the Jiangxi province of Southern Central China. An ECS panel encompassing 147 genes associated with 155 genetic disorders was initially performed on 5,104 pre-gestational/prenatal females using next-generation sequencing. Following the identification of autosomal recessive conditions in female partners, sequential genetic testing was offered to 1,351 male partners, which included either the same ECS panel or other appropriate genetic tests. Comprehensive reproductive counseling was provided to all the identified at-risk couples (ARCs). Overall, 6,308 participants accepted ECS for 155 conditions (Female: 5,104, Male: 1,204) and approximately 38.43% (2,424/6,308) of them were detected as carriers for at least one of the 155 genetic conditions. The top four prevalent conditions identified in Jiangxi Province were α-thalassemia, GJB2-associated hearing loss, Krabbe disease and Wilson’s disease. Among the participated cohort, 1,960 females were identified with AR variants and 1,351 male partners received sequential testing, at a recall rate of 68.93%. Among the tested couples, a total of 36 ARCs (36/1,357, 2.65%) were identified with the same AR (n = 27) or X-linked conditions (n = 9). Our study represents the first large-scale demonstration of the substantial feasibility of ECS in the Jiangxi population of Southern Central China. Based on our findings, we propose that incorporating genes with a carrier frequency threshold of 1/2,000 in the screening panel could serve as an optimal criterion. Our findings may contribute significantly to facilitating future clinical implementations of ECS.Keywords
Funding Information
- Jiangxi Provincial Science and Technology Plan Projects of Traditional Chinese Medicine (20232B1258)
- Jiangxi Provincial Natural Science Foundation (20232BAB216025)
- Jiangxi province key research and development project (20232BBG70023)
This publication has 37 references indexed in Scilit:
- Customizing carrier screening in the Chinese population: Insights from a 334‐gene panelPrenatal Diagnosis, 2024
- Carrier burden of over 300 diseases in Han Chinese identified by expanded carrier testing of 300 couples using assisted reproductive technologyJournal of Assisted Reproduction and Genetics, 2023
- A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in ChinaWorld Journal of Pediatrics, 2023
- Reproductive male partner testing when the female is identified to be a genetic disease carrierPrenatal Diagnosis, 2020
- Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technologyMolecular Genetics & Genomic Medicine, 2020
- Expanded genetic carrier screening in clinical practice: a current survey of patient impressions and attitudesJournal of Assisted Reproduction and Genetics, 2019
- Dystrophin-Deficient CardiomyopathyJACC, 2016
- Birth defects surveillance in ChinaWorld Journal of Pediatrics, 2011
- Prevalence and incidence of Becker muscular dystrophyThe Lancet, 1991
- Population frequencies of neuromuscular diseases—II. Amyotrophic lateral sclerosis (motor neurone disease)Neuromuscular Disorders, 1991